Sanofi's Strategic Move: A €3 Billion Share Buyback

In a significant financial maneuver, Sanofi S.A. has announced its decision to repurchase 2.3% of its shares from L'Oreal S.A. This transaction, part of a share buyback program initiated on January 30, involves the acquisition of 29,556,650 shares at a price of €101.50 each, marking a 2.8% discount from the closing price on January 31, 2025.

Strengthening Ties with L'Oreal

Post-transaction, L'Oreal's stake in Sanofi will adjust to 7.2%, with 13.1% of voting rights. This move underscores the enduring partnership between the two giants, with Sanofi's CFO, Francois Roger, highlighting L'Oreal's pivotal role in Sanofi's growth and transformation. "L'Oreal has been a trusted shareholder and partner for decades, playing a key role in supporting Sanofi’s growth and transformation. We are pleased to retain L'Oreal as one of our largest shareholders," Roger stated.

Commitment to Sustainable Value Creation

This transaction is a testament to Sanofi's commitment to sustainable value creation, ensuring the preservation of strategic priorities and the strength of key partnerships. It reflects a forward-looking approach to corporate strategy, balancing immediate financial maneuvers with long-term partnership and growth objectives.